Links Home FDA Information

Arixtra This page contains recent news articles, when available, and an overview of Arixtra (fondaparinux)Recent news articles mentioning Arixtra GSK gets non-approvable FDA letter for Arixtra indications  -  Feb 5, 2007 Pharma Times (subscription), GlaxoSmithKline's plans to get its anticoagulant drug Arixtra approved in a new indication have been set back somewhat by the US Food and Drug Approvable Letter Issued for New Arixtra Indications  -  Feb 5, 2007 Facts and Comparisons, The FDA has issued an approvable letter to GlaxoSmithKline’s Arixtra (fondaparinux sodium) injection for the treatment of patients with unstable angina or GlaxoSmithKline Receives Approvable Letter For New Indications For ...  -  Feb 5, 2007 Medical News Today (press release), GSK will continue to work with the FDA to provide the additional information requested to complete the assessment of ARIXTRA for these indications. CORRECTION GlaxoSmithKline gets FDA approvable letter for new use ...  -  Feb 2, 2007 Forbes, An injectable drug, Arixtra is currently used in patients undergoing certain types of surgery who are at risk for blood clot-complications. GlaxoSmithKline asked for additional information by the FDA on Arixtra  -  Feb 2, 2007 International Herald Tribune, Arixtra is already approved for use during surgery in patients at risk for blood clots. The company did not elaborate on the FDA's request, but said it will GSK's Arixtra OK'd on 2 cardiac uses  -  Feb 2, 2007 United Press International 2 (UPI) -- GlaxoSmithKline said Friday it got an approvable letter from the US Food and Drug Administration on two new uses for its injectable, Arixtra. New Use Expected for Glaxo Drug  -  Jan 31, 2007 Forbes, The Food and Drug Administration is scheduled to issue a decision Thursday on whether to approve Arixtra as a treatment for acute coronary syndrome, TAKING STOCK  -  Feb 6, 2007 Therapeutics Daily (subscription) (press release), The US Food and Drug Administration has approved a new use for GlaxoSmithKline's anticoagulant drug Arixtra. It can now be used to treat acute coronary What the doctor ordered  -  Feb 5, 2007 The Australian, Alchemia (ACL, $1.14) surged 40 per cent last week ahead of yesterday's disclosure the FDA had approved use of the anti-cholesterol drug Arixtra. UK FTSE 100 Advances; Sainsbury, Tesco and Morrison Gain  -  Feb 2, 2007 Bloomberg Europe's largest drugmaker said US regulators asked for more information on its injectable blood- thinning medicine Arixtra for heart attacks. Business news in brief  -  Feb 3, 2007 Philadelphia Inquirer, GlaxoSmithKline PLC, Europe's largest drugmaker, said US regulators asked for more information on its injectable blood-thinning medicine Arixtra for heart (PRN) - Concreteideas.com: A New Resource for Decorative Concrete ...  -  Feb 2, 2007 Bolsamania.com, ...(PRN) - GlaxoSmithKline Receives Approvable Letter for New Indications for ARIXTRA(R) (Fondaparinux Sodium) Injection ... [+] Market highlights For next week: Google reporting Q4 earnings ...  -  Jan 26, 2007 Blogging Stocks PDUFA date for GlaxoSmithKline plc's (NYSE: GSK) Arixtra for acute coronary syndromes. Broadcom Corporation (NADSAQ: BRCM) and SafeNet Inc (NASDAQ: SFNT)